U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H19N5O4S
Molecular Weight 377.418
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SELURAMPANEL

SMILES

CC(C)C1=CC2=C(C=C1C3=CC=NN3C)C(=O)N(NS(C)(=O)=O)C(=O)N2

InChI

InChIKey=MCECSFFXUPEPDB-UHFFFAOYSA-N
InChI=1S/C16H19N5O4S/c1-9(2)10-8-13-12(7-11(10)14-5-6-17-20(14)3)15(22)21(16(23)18-13)19-26(4,24)25/h5-9,19H,1-4H3,(H,18,23)

HIDE SMILES / InChI
Selurampanel (previously known as BGG 492), an orally available, AMPA-type glutamate receptor (AMPAR)/kainate receptor (GluK1; GluR5) antagonist was developed by Novartis. It is known that AMPAR antagonism is under development as a novel mechanism of action for antiepileptic drugs. Selurampanel was studied in phase II clinical trial for the migraine treatment. However, Proof-of-concept criterion was not met. In addition, the drug also participated in phase II clinical trials in therapy-refractory partial seizures for epilepsy surgery and in patients with chronic subjective tinnitus. Development of selurampanel for all these diseases was discontinued as of September 2017.

Approval Year

PubMed

PubMed

TitleDatePubMed
Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks.
2014 Feb
BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy.
2014 Jan
Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor Antagonist.
2017 Feb 3
Patents

Sample Use Guides

BGG492 (SELURAMPANEL) (250 mg), vs placebo and sumatriptan (100 mg), in 75 subjects with acute migraine attacks
Route of Administration: Oral
Name Type Language
SELURAMPANEL
INN   WHO-DD  
INN  
Official Name English
BGG-492
Code English
N-(6-(1-METHYL-1H-PYRAZOL-5-YL)-7-(PROPAN-2-YL)-2,4-DIOXO-1,4-DIHYDROQUINAZOLIN-3(2H)-YL)METHANESULFONAMIDE
Systematic Name English
BGG492
Code English
Selurampanel [WHO-DD]
Common Name English
METHANESULFONAMIDE, N-(1,4-DIHYDRO-7-(1-METHYLETHYL)-6-(1-METHYL-1H-PYRAZOL-5-YL)-2,4-DIOXO-3(2H)-QUINAZOLINYL)-
Systematic Name English
selurampanel [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C264
Created by admin on Fri Dec 15 19:21:51 GMT 2023 , Edited by admin on Fri Dec 15 19:21:51 GMT 2023
Code System Code Type Description
PUBCHEM
45381907
Created by admin on Fri Dec 15 19:21:51 GMT 2023 , Edited by admin on Fri Dec 15 19:21:51 GMT 2023
PRIMARY
FDA UNII
7WG1MR7DAR
Created by admin on Fri Dec 15 19:21:51 GMT 2023 , Edited by admin on Fri Dec 15 19:21:51 GMT 2023
PRIMARY
SMS_ID
100000178146
Created by admin on Fri Dec 15 19:21:51 GMT 2023 , Edited by admin on Fri Dec 15 19:21:51 GMT 2023
PRIMARY
WIKIPEDIA
Selurampanel
Created by admin on Fri Dec 15 19:21:51 GMT 2023 , Edited by admin on Fri Dec 15 19:21:51 GMT 2023
PRIMARY
CAS
912574-69-7
Created by admin on Fri Dec 15 19:21:51 GMT 2023 , Edited by admin on Fri Dec 15 19:21:51 GMT 2023
PRIMARY
NCI_THESAURUS
C152327
Created by admin on Fri Dec 15 19:21:51 GMT 2023 , Edited by admin on Fri Dec 15 19:21:51 GMT 2023
PRIMARY
ChEMBL
CHEMBL3545042
Created by admin on Fri Dec 15 19:21:51 GMT 2023 , Edited by admin on Fri Dec 15 19:21:51 GMT 2023
PRIMARY
INN
9393
Created by admin on Fri Dec 15 19:21:51 GMT 2023 , Edited by admin on Fri Dec 15 19:21:51 GMT 2023
PRIMARY
DRUG BANK
DB12367
Created by admin on Fri Dec 15 19:21:51 GMT 2023 , Edited by admin on Fri Dec 15 19:21:51 GMT 2023
PRIMARY
EPA CompTox
DTXSID00238467
Created by admin on Fri Dec 15 19:21:51 GMT 2023 , Edited by admin on Fri Dec 15 19:21:51 GMT 2023
PRIMARY